Goldman Sachs’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.64K | Sell |
|
|||||
|
2022
Q4 | $50.5K | Sell |
|
|||||
|
2022
Q3 | $71K | Sell |
|
|||||
|
2022
Q2 | $89K | Sell |
|
|||||
|
2022
Q1 | $183K | Buy |
|
|||||
|
2021
Q4 | $302K | Buy |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $368K | Buy |
|
|||||
|
2021
Q1 | $150K | Buy |
|
|||||
|
2020
Q4 | $136K | Buy |
|
|||||
|
2020
Q3 | $54K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2.42M | Sell |
|
|||||
|
2019
Q1 | $2.16M | Sell |
|
|||||
|
2018
Q4 | $3.71M | Sell |
|
|||||
|
2018
Q3 | $3.82M | Sell |
|
|||||
|
2018
Q2 | $3.97M | Buy |
|